Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jiro Ando is active.

Publication


Featured researches published by Jiro Ando.


Cancer Science | 2008

Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer.

Kokichi Sugano; Seigo Nakamura; Jiro Ando; Shin Takayama; Hiroyuki Kamata; Isao Sekiguchi; Megumi Ubukata; Tetsuro Kodama; Masami Arai; Fujio Kasumi; Yasuo Hirai; Tadashi Ikeda; Hiromitsu Jinno; Masaki Kitajima; Daisuke Aoki; Akira Hirasawa; Yuko Takeda; Kumiko Yazaki; Takashi Fukutomi; Takayuki Kinoshita; Ryuichiro Tsunematsu; Teruhiko Yoshida; Masako Izumi; Shino Umezawa; Hiroshi Yagata; Hiroko Komatsu; Naoko Arimori; Noriko Matoba; Nobuhisa Gondo; Shiro Yokoyama

The prevalence of BRCA1/2 germline mutations in Japanese patients suspected to have hereditary breast/ovarian cancer was examined by a multi‐institutional study, aiming at the clinical application of total sequencing analysis and validation of assay sensitivity in Japanese people using a cross‐sectional approach based on genetic factors estimated from personal and family histories. One hundred and thirty‐five subjects were referred to the genetic counseling clinics and enrolled in the study. Full sequencing analysis of the BRCA1/2 gene showed 28 types of deleterious mutations in 36 subjects (26.7%), including 13 types of BRCA1 mutations in 17 subjects (12.6%) and 15 types of BRCA2 mutations in 19 subjects (14.1%). Subjects were classified into five groups and 22 subgroups according to their personal and family history of breast and/or ovarian cancer, and the prevalence of deleterious mutations was compared with previously reported data in non‐Ashkenazi individuals. Statistical analysis using the Mantel‐Haenszel test for groups I through IV revealed that the prevalence of Japanese subjects was significantly higher than that of non‐Ashkenazi individuals (P = 0.005, odds ratio 1.87, 95% confidence interval 1.22–2.88). Family history of the probands suffering from breast cancer indicated risk factors for the presence of deleterious mutations of BRCA1/2 as follows: (1) families with breast cancer before age 40 within second degree relatives (P = 0.0265, odds ratio 2.833, 95% confidence interval 1.165–7.136) and (2) families with bilateral breast cancer and/or ovarian cancer within second degree relatives (P = 0.0151, odds ratio 2.88, 95% confidence interval 1.25–6.64). (Cancer Sci 2008; 99: 1967–1976)


Archives of Plastic Surgery | 2018

A novel technique for large and ptotic breast reconstruction using a latissimus dorsi myocutaneous flap set at the posterior aspect, combined with a silicone implant, following tissue expander surgery

Naohiro Ishii; Jiro Ando; Yusuke Shimizu; Kazuo Kishi

Large and ptotic breast reconstruction in patients who are not candidates for a transverse rectus abdominalis myocutaneous flap and revision surgery for the contralateral breast remains challenging. We developed a novel breast reconstruction technique using a latissimus dorsi myocutaneous (LD m-c) flap set at the posterior aspect of the reconstructed breast, combined with an anatomical silicone breast implant (SBI), following tissue expander surgery. We performed the proposed technique in four patients, in whom the weight of the resected tissue during mastectomy was >500 g and the depth of the inframammary fold (IMF) was >3 cm. After over-expansion of the lower portion of the skin envelope by a tissue expander, the LD m-c flap was transferred to cover the lower portion of the breast defect and to achieve a ptotic contour, with the skin paddle set at the posterior aspect of the reconstructed breast. An SBI was then placed in the rest of the breast defect after setting the LD m-c flap. No major complications were observed during the follow-up period. The proposed technique resulted in symmetrical and aesthetically satisfactory breasts with deep IMFs, which allowed proper fitting of the brassiere, following large and ptotic breast reconstruction.


Aesthetic Plastic Surgery | 2018

Influence of Flap Thickness on Nipple Projection After Nipple Reconstruction Using a Modified Star Flap

Naohiro Ishii; Jiro Ando; Michiko Harao; Masaru Takemae; Kazuo Kishi

BackgroundIn nipple reconstruction, the width, length, and thickness of modified star flaps are concerns for long-term reconstructed nipple projection. However, the flap’s projection has not been analyzed, based on its thickness. The aim of the present study was to investigate how flap thickness in a modified star flap influences the resulting reconstructed nipple and achieves an appropriate flap width in design.MethodsSixty-three patients who underwent nipple reconstruction using a modified star flap following implant-based breast reconstruction between August 2014 and July 2016 were included in this case-controlled study. The length of laterally diverging flaps was 1.5 times their width. The thickness of each flap was measured using ultrasonography, and the average thickness was defined as the flap thickness. We investigated the correlation between the resulting reconstructed nipple and flap thickness, and the difference of the change in the reconstructed nipple projection after using a thin or thick flap.ResultsThe average flap thickness was 3.8 ± 1.7 (range 2.5–6.0) mm. There was a significant, linear correlation between the flap thickness and resulting reconstructed nipple projection (β = 0.853, p < 0.01). Furthermore, the difference between the thin and thick flaps in the resulting reconstructed nipple projection was significant (p < 0.01).ConclusionMeasuring the flap thickness preoperatively may allow surgeons to achieve an appropriate flap width; otherwise, alternative methods for higher projection might be used.Level of Evidence IVThis journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.


Gland surgery | 2017

Breast reconstruction of an unusual configuration using two paranemic implants

Naohiro Ishii; Jiro Ando; Michiko Harao; Masaru Takemae

Implant-based breast reconstruction can be performed using a choice of various types of breast implants. However, cases where the breast shapes are unsuitable for implant-based reconstruction method are occasionally encountered. We present two patients with wide trunks who underwent breast reconstruction using an unusual configuration that involved a latissimus dorsi myocutaneous flap combined with two paranemic implants.


Archives of Plastic Surgery | 2017

Complete Coverage of a Tissue Expander by a Musculofascial Pocket Including the Sternalis Muscle during Breast Reconstruction

Naohiro Ishii; Yusuke Shimizu; Jiro Ando; Michiko Harao; Masaru Takemae; Kazuo Kishi

Naohiro Ishii, Yusuke Shimizu, Jiro Ando, Michiko Harao, Masaru Takemae, Kazuo Kishi Department of Plastic and Reconstructive Surgery, Tochigi Cancer Center, Tochigi; Department of Plastic and Reconstructive Surgery, University of the Ryukyus Hospital, Okinawa; Department of Breast Surgery, Tochigi Cancer Center, Tochigi; Department of Plastic and Reconstructive Surgery, Keio University, Tokyo, Japan


Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi | 1999

Evaluation of the Pylorusfunction after Pylorus-Preserving Distal Gastrectomy by the Gastrointestinal and Biliary Scintigraphy.

Takao Inada; Yoshiro Ogata; Seichiro Yamamoto; Jiro Ando; Iwao Ozawa; Junichi Matsui; Shoichi Hishinuma; Hideaki Shimizu; Kenjiro Kotake

幽門保存胃切除例(pylorus preserving distal gastrectomy: 以下, PPDG と略記)8例を対象として, 消化管・胆道シンチグラフィーによる術後機能評価を行い, 早期胃癌術前症例および通常の幽門側切除, Billroth-1法吻合症例(以下, B-1と略記)との比較を行った. 胆道シンチグラフィーによる胆汁排泄開始時間はPPDG群, 術前群, B-1群において有意な差異は認められなかった. また胆汁の残胃内逆流は, B-1では40%以上に認められるのに対し, PPDG群では術後6か月, 1年ともに, 術前群と同様に認められなかった. 消化管シンチグラフィーによる食物の胃からの排出は, PPDG群では術後6か月において, 術前群, B-1群と比べて有意な停滞が認められるものの, 術後1年の比較では, B-1群と差が認められず, 幽門機能の経時的な回復が示唆された.


Japanese Journal of Clinical Oncology | 1999

A PHASE I/II STUDY OF CONTINUOUS INTRA-ARTERIAL CHEMOTHERAPY USING AN IMPLANTABLE RESERVOIR FOR THE TREATMENT OF LIVER METASTASES FROM BREAST CANCER : A JAPAN CLINICAL ONCOLOGY GROUP (JCOG) STUDY 9113

Tadashi Ikeda; Isamu Adachi; Shigemitsu Takashima; Masami Ogita; Hideaki Aoyama; Muneaki Sano; Jiro Ando; Toshio Tabei; Takeshi Tominaga; Kohji Enomoto; Kazuhiro Kanda; Takashi Fukutomi; Masanori Shimoyama


Japanese Journal of Clinical Oncology | 2007

Relative and Combined Performance of Mammography and Ultrasonography for Breast Cancer Screening in the General Population: a Pilot Study in Tochigi Prefecture, Japan

Satoshi Honjo; Jiro Ando; Takeo Tsukioka; Hiroshi Morikubo; Miyuki Ichimura; Masakatsu Sunagawa; Toshihiko Hasegawa; Teruki Watanabe; Tetsuro Kodama; Keigo Tominaga; Michizo Sasagawa; Yasuo Koyama


Jpn J Gastroenterol Surg, Nihon Shokaki Geka Gakkai zasshi | 1995

Evaluation of Peritoneal Lavage Cytology in Patients with Advanced Colorectal Cancer.

Jiro Nasu; Kenjiro Kotake; Yasuo Koyama; Hideaki Shimizu; Shoichi Hishinuma; Takao Inada; Junichi Matsui; Iwao Ozawa; Jiro Ando; Yoshiro Ogata


Journal of Plastic Reconstructive and Aesthetic Surgery | 2017

Decreased contralateral breast volume after mastectomy, adjuvant chemotherapy, and anti-estrogen therapy, in particular in breasts with high density

Naohiro Ishii; Jiro Ando; Michiko Harao; Masaru Takemae; Kazuo Kishi

Collaboration


Dive into the Jiro Ando's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yasuo Koyama

Kansai Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge